FIELD: chemistry; pharmaceutics.
SUBSTANCE: invention refers to vortioxetine pyroglutamate, including in crystalline form, to a pharmaceutical composition and gel containing said salt.
EFFECT: aim of the present invention is to provide vortioxetine salts which can be administered as an oral gel without the need for gelling polymers.
18 cl, 14 dwg, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR THE PRODUCTION OF THE ALPHA FORM OF VORTIOXETINE HBr | 2018 |
|
RU2778239C2 |
| COMPOSITIONS CONTAINING VORTIOXETINE AND DONEPEZIL | 2013 |
|
RU2635528C2 |
| DOSAGE FORMS, SALTS AND POLYMORPHS OF TRANSNORSERTRALINE AND USING THEM | 2010 |
|
RU2578956C2 |
| COMPOSITIONS CONTAINING BENZOATE COMPOUND AND TANNIC ACID FOR TREATMENT OF DISORDER OF CENTRAL NERVOUS SYSTEM | 2017 |
|
RU2756812C2 |
| POLYMORPHOUS FORM OF 3-PHENYLSULFONYL-8-PIPERASINE-1-YL-QUINOLINE | 2004 |
|
RU2355681C2 |
| USE OF OPIOID RECEPTOR ANTAGONIST WITH K-ACTIVITY AND VORTIOXETINE FOR TREATMENT OF DEPRESSIVE DISORDER WITH MELANCHOLIC FEATURES | 2014 |
|
RU2679661C1 |
| IMIDAZODIAZEPINE COMPOUND | 2016 |
|
RU2777915C2 |
| IMIDAZODIAZEPINE COMPOUND | 2016 |
|
RU2712968C2 |
| TOSYLATE SALT OF TRANS-N-ISOBUTYL-3-FLUORO-3-[3-FLUORO-4-(PYRROLIDIN-1-YLMETHYL)PHENYL]CYCLOBUTANE CARBOXAMIDE | 2008 |
|
RU2451016C2 |
| CITRIC SALT OF INDOLE DERIVATIVE, METHOD FOR PRODUCING THEREOF, ADMINISTERING THEREOF AND BASED PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2415137C2 |
